{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:34:09Z","timestamp":1790102049315,"version":"4.0.1"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.111937","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T09:55:03Z","timestamp":1712051703000},"page":"111937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Adjunctive administration of parabiotic Lactobacillus sakei CVL-001 ameliorates drug-induced toxicity and pulmonary inflammation during antibiotic treatment for tuberculosis"],"prefix":"10.1016","volume":"132","author":[{"given":"Hagyu","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunsol","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Woong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Jae","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.111937_b0005","unstructured":"W.H. Organization, Global tuberculosis report 2023, World Health Organization. (2023)."},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0010","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0040120","article-title":"Why is long-term therapy required to cure tuberculosis?","volume":"4","author":"Connolly","year":"2007","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and Management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"10","key":"10.1016\/j.intimp.2024.111937_b0020","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1183\/09031936.96.09102026","article-title":"Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis","volume":"9","author":"Schaberg","year":"1996","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.intimp.2024.111937_b0025","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2024.111937_b0030","first-page":"e920350","article-title":"Drug-induced liver injury from anti-tuberculosis treatment: a retrospective cohort study","volume":"26","author":"Zhao","year":"2020","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.intimp.2024.111937_b0035","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.111937_b0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2020.09.038","article-title":"Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests","volume":"82","author":"Patterson","year":"2021","journal-title":"J. Infect."},{"issue":"6","key":"10.1016\/j.intimp.2024.111937_b0045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1164\/rccm.201105-0850OC","article-title":"A comparison between two strategies for monitoring hepatic function during antituberculous therapy","volume":"185","author":"Singanayagam","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2024.111937_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/HMER.S290542","article-title":"Anti-tuberculosis drug induced hepatotoxicity and associated factors among tuberculosis patients at selected hospitals Ethiopia","volume":"13","author":"Molla","year":"2021","journal-title":"Hepat. Med."},{"issue":"7","key":"10.1016\/j.intimp.2024.111937_b0055","doi-asserted-by":"crossref","first-page":"e1002595","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies","volume":"15","author":"Alipanah","year":"2018","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.intimp.2024.111937_b0060","doi-asserted-by":"crossref","first-page":"e3089","DOI":"10.1371\/journal.pone.0003089","article-title":"Directly observed therapy and improved tuberculosis treatment outcomes in Thailand","volume":"3","author":"Anuwatnonthakate","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.111937_b0065","doi-asserted-by":"crossref","DOI":"10.1093\/nutrit\/nuad120","article-title":"Effectiveness of nutritional support to improve treatment adherence in patients with tuberculosis: a systematic review","author":"Wagnew","year":"2023","journal-title":"Nutr. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2024.111937_b0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41385-019-0226-5","article-title":"Therapeutic host-directed strategies to improve outcome in tuberculosis","volume":"13","author":"Young","year":"2020","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/ker215","article-title":"Dynamic regulation of glucocorticoid signalling in health and disease","volume":"51","author":"Biddie","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: Mechanisms of Action in Health and Disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"11","key":"10.1016\/j.intimp.2024.111937_b0085","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/infdis\/jit476","article-title":"Low-dose aspirin and ibuprofen's sterilizing effects on Mycobacterium tuberculosis suggest safe new adjuvant therapies for tuberculosis","volume":"208","author":"Eisen","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2024.111937_b0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/infdis\/jit152","article-title":"Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis","volume":"208","author":"Vilaplana","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0095","first-page":"188","article-title":"Globus of the pharynx? differential diagnosis","volume":"48","author":"Kellerhals","year":"1991","journal-title":"Ther. Umsch."},{"issue":"8","key":"10.1016\/j.intimp.2024.111937_b0100","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/0883073811398132","article-title":"The role of aspirin in childhood tuberculous meningitis","volume":"26","author":"Schoeman","year":"2011","journal-title":"J. Child. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/AAC.00735-10","article-title":"Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor","volume":"55","author":"Kalle","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.intimp.2024.111937_b0110","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.bmc.2015.03.041","article-title":"Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore","volume":"23","author":"Salunke","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2024.111937_b0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Fan Chung","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111937_b0120","first-page":"391-414","article-title":"Phosphodiesterase inhibitors in the treatment of inflammatory diseases","volume":"204","author":"Page","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111937_b0125","doi-asserted-by":"crossref","first-page":"e17091","DOI":"10.1371\/journal.pone.0017091","article-title":"Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice","volume":"6","author":"Koo","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.intimp.2024.111937_b0130","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1128\/AAC.02145-15","article-title":"Roflumilast, a type 4 phosphodiesterase inhibitor, shows promising adjunctive, host-directed therapeutic activity in a mouse model of tuberculosis","volume":"59","author":"Maiga","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.intimp.2024.111937_b0135","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760170326","article-title":"Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis","volume":"113","author":"Lopez-Lopez","year":"2018","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.intimp.2024.111937_b0140","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1165\/rcmb.2006-0478OC","article-title":"Tuberculosis susceptibility of diabetic mice","volume":"37","author":"Martens","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2024.111937_b0145","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/infdis\/jiw436","article-title":"Impaired recognition of Mycobacterium tuberculosis by Alveolar macrophages from diabetic mice","volume":"214","author":"Martinez","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0150","doi-asserted-by":"crossref","first-page":"e92977","DOI":"10.1371\/journal.pone.0092977","article-title":"Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia","volume":"9","author":"Restrepo","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diabetes.55.01.06.db05-0943","article-title":"Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells","volume":"55","author":"Kukidome","year":"2006","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.intimp.2024.111937_b0160","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.111937_b0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3389\/fimmu.2020.00891","article-title":"Evaluation of IL-1 blockade as an adjunct to linezolid therapy for tuberculosis in mice and macaques","volume":"11","author":"Winchell","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.111937_b0170","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/03079457.2021.1983153","article-title":"Hepatoprotective effects of Lactobacillus plantarum 299v supplemented via drinking water against aflatoxin-induced liver damage","volume":"50","author":"Allameh","year":"2021","journal-title":"Avian Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2024.111937_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082212","article-title":"Hepatoprotective effects of Lactobacillus on Carbon Tetrachloride-induced acute liver injury in mice","volume":"19","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.111937_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111533","article-title":"Lactobacillus plantarum LP33 attenuates Pb-induced hepatic injury in rats by reducing oxidative stress and inflammation and promoting Pb excretion","volume":"143","author":"Hu","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2024.111937_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.869250","article-title":"Probiotic lactobacilli ameliorate alcohol-induced hepatic damage via gut microbial alteration","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.intimp.2024.111937_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119444","article-title":"Regulation of gut microflora by Lactobacillus casei zhang attenuates liver injury in mice caused by anti-tuberculosis drugs","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0195","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00384-21","article-title":"Lactobacillus acidophilus LA14 Alleviates Liver Injury","volume":"6","author":"Lv","year":"2021","journal-title":"mSystems"},{"issue":"10","key":"10.1016\/j.intimp.2024.111937_b0200","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S2213-2600(18)30501-0","article-title":"The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda","volume":"7","author":"Naidoo","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.intimp.2024.111937_b0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fimmu.2018.00142","article-title":"The metabolic sensor GPR43 receptor plays a role in the control of Klebsiella pneumoniae infection in the lung","volume":"9","author":"Galvao","year":"2018","journal-title":"Front. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2024.111937_b0210","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1513\/AnnalsATS.201503-133AW","article-title":"The gut-lung Axis in respiratory disease","volume":"12","author":"Marsland","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.intimp.2024.111937_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.578386","article-title":"Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body","volume":"12","author":"Cristofori","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.111937_b0220","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1756308","article-title":"Probiotic cell-free supernatants exhibited anti-inflammatory and antioxidant activity on human gut epithelial cells and macrophages stimulated with LPS","author":"De Marco","year":"2018","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.intimp.2024.111937_b0225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fimmu.2016.00273","article-title":"Probiotic lactobacilli modulate Staphylococcus aureus-induced activation of conventional and unconventional T cells and NK cells","volume":"7","author":"Johansson","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.111937_b0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.intimp.2016.03.033","article-title":"Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through toll-like receptor 2-dependent induction of T-regulatory response","volume":"36","author":"Thakur","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111937_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.908010","article-title":"The beneficial role of probiotic Lactobacillus in respiratory diseases","volume":"13","author":"Du","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.111937_b0240","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.4049\/jimmunol.2001044","article-title":"A Pulmonary Lactobacillus murinus strain induces Th17 and RORgammat(+) regulatory T cells and reduces lung inflammation in tuberculosis","volume":"207","author":"Bernard-Raichon","year":"2021","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2024.111937_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/nu15133074","article-title":"Effect of Lactobacillus sakei OK67 in reducing body and visceral fat in lifestyle-modified overweight individuals: a 12-week, randomized, double-blind, placebo-controlled clinical trial","volume":"15","author":"Oh","year":"2023","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.intimp.2024.111937_b0250","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3803\/EnM.2020.35.2.425","article-title":"Effect of lactobacillus sakei, a probiotic derived from kimchi, on body fat in koreans with obesity: a randomized controlled study","volume":"35","author":"Lim","year":"2020","journal-title":"Endocrinol Metab (seoul)"},{"issue":"4","key":"10.1016\/j.intimp.2024.111937_b0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.anai.2010.01.020","article-title":"Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome","volume":"104","author":"Woo","year":"2010","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111937_b0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12602-020-09654-7","article-title":"Oral administration of live and dead cells of lactobacillus sakei proBio65 alleviated atopic dermatitis in children and adolescents: a randomized","volume":"13","author":"Rather","year":"2021","journal-title":"Double-Blind, and Placebo-Controlled Study, Probiotics Antimicrob Proteins"},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12967-020-02477-8","article-title":"Lactobacillus sakei suppresses collagen-induced arthritis and modulates the differentiation of T helper 17 cells and regulatory B cells","volume":"18","author":"Jhun","year":"2020","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.111937_b0270","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/08923973.2016.1233981","article-title":"Lactobacillus sakei K17, an inducer of IL-10 expression in antigen-presenting cells, attenuates TNBS-induced colitis in mice","volume":"38","author":"Eun","year":"2016","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"8","key":"10.1016\/j.intimp.2024.111937_b0275","doi-asserted-by":"crossref","first-page":"e0273604","DOI":"10.1371\/journal.pone.0273604","article-title":"Identification of novel lactic acid bacteria with enhanced protective effects against influenza virus","volume":"18","author":"Sugimoto","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.intimp.2024.111937_b0280","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1111\/jam.14773","article-title":"Lactic acid bacteria feeding reversed the malformed eye structures and ameliorated gut microbiota profiles of drosophila melanogaster alzheimer's disease model","volume":"132","author":"Liu","year":"2022","journal-title":"J. Appl. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111937_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11051359","article-title":"Oral Administration of Lactobacillus sakei CVL-001 improves recovery from dextran sulfate sodium-induced colitis in mice by Microbiota modulation","volume":"11","author":"Kim","year":"2023","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0290","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1038\/s41598-019-52146-0","article-title":"Long-term protective efficacy with a BCG-prime ID93\/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model","volume":"9","author":"Kwon","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0295","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1038\/s41467-022-30914-3","article-title":"Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx","volume":"13","author":"Kang","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2024.111937_b0300","article-title":"Antigen-specific IFN-gamma\/IL-17-co-producing CD4(+) T-cells are the determinants for protective efficacy of tuberculosis subunit vaccine","volume":"8","author":"Choi","year":"2020","journal-title":"Vaccines (basel)"},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0305","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2018.08.001","article-title":"Alveolar macrophages provide an early mycobacterium tuberculosis niche and initiate dissemination","volume":"24","author":"Cohen","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.intimp.2024.111937_b0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00281-016-0560-6","article-title":"Key mechanisms governing resolution of lung inflammation","volume":"38","author":"Robb","year":"2016","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thorax.55.1.32","article-title":"Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment","volume":"55","author":"Hnizdo","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2024.111937_b0320","doi-asserted-by":"crossref","first-page":"1146571","DOI":"10.3389\/fcimb.2023.1146571","article-title":"Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease","volume":"13","author":"Kayongo","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0325","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12890-020-1167-1","article-title":"Development of chronic lung impairment in mozambican TB patients and associated risks","volume":"20","author":"Khosa","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0330","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/thoraxjnl-2019-213808","article-title":"Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study","volume":"75","author":"Meghji","year":"2020","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.intimp.2024.111937_b0335","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1378\/chest.06-2949","article-title":"Pulmonary impairment after tuberculosis","volume":"131","author":"Pasipanodya","year":"2007","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.intimp.2024.111937_b0340","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/thx.2009.129999","article-title":"Excess lung function decline in gold miners following pulmonary tuberculosis","volume":"65","author":"Ross","year":"2010","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.intimp.2024.111937_b0345","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4046\/trd.2021.0127","article-title":"Pulmonary functions and inflammatory Biomarkers in post-Pulmonary tuberculosis sequelae","volume":"85","author":"Shanmugasundaram","year":"2022","journal-title":"Tuberc Respir Dis (seoul)"},{"key":"10.1016\/j.intimp.2024.111937_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.684588","article-title":"Hepatoprotective effect of Lactobacillus plantarum HFY09 on ethanol-induced liver injury in mice","volume":"8","author":"Gan","year":"2021","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0355","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12866-019-1525-4","article-title":"Lactobacillus plantarum C88 protects against aflatoxin B(1)-induced liver injury in mice via inhibition of NF-kappaB-mediated inflammatory responses and excessive apoptosis","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0360","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","article-title":"The current state of serum biomarkers of hepatotoxicity","volume":"245","author":"Ozer","year":"2008","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the framingham heart study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0370","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2008.05.022","article-title":"Uric acid: a marker of increased cardiovascular risk","volume":"202","author":"Gagliardi","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0375","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","article-title":"Uric acid as a danger signal in gout and its comorbidities","volume":"9","author":"Rock","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.111937_b0380","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/382918","article-title":"Uric acid as a marker of kidney disease: review of the current literature","volume":"2015","author":"Giordano","year":"2015","journal-title":"Dis. Markers"},{"issue":"5","key":"10.1016\/j.intimp.2024.111937_b0385","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jpeds.2012.12.078","article-title":"Uric acid and the origins of hypertension","volume":"162","author":"Feig","year":"2013","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.intimp.2024.111937_b0390","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2005090949","article-title":"Uric acid and endothelial dysfunction in essential hypertension","volume":"17","author":"Zoccali","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"19","key":"10.1016\/j.intimp.2024.111937_b0395","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/CIRCULATIONAHA.106.657627","article-title":"Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents","volume":"115","author":"Ford","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2024.111937_b0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","article-title":"Uric acid in metabolic syndrome: from an innocent bystander to a central player","volume":"29","author":"Kanbay","year":"2016","journal-title":"Eur. J. Intern. Med."},{"issue":"14","key":"10.1016\/j.intimp.2024.111937_b0405","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM197204062861407","article-title":"Hyperuricemia due to ethambutol","volume":"286","author":"Postlethwaite","year":"1972","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.111937_b0410","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0002-9343(57)90230-9","article-title":"Hyperuricemia due to pyrazinamide","volume":"23","author":"Shapiro","year":"1957","journal-title":"Am. J. Med."},{"issue":"03","key":"10.1016\/j.intimp.2024.111937_b0415","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0041-1724022","article-title":"Unnoticed adverse effect of isoniazid during childhood tuberculosis preventive treatment: hyperuricemia","volume":"16","author":"Kandemir","year":"2021","journal-title":"J. Pediatr. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.111937_b0420","first-page":"008","article-title":"Ruta graveolens protects against isoniazid\/rifampicin-induced nephrotoxicity through modulation of oxidative stress and inflammation","volume":"2","author":"Hussein","year":"2016","journal-title":"Glob. J. Biotechnol. Biomater. Sci."},{"key":"10.1016\/j.intimp.2024.111937_b0425","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.freeradbiomed.2015.09.022","article-title":"The neuronal nitric oxide synthase inhibitor NANT blocks acetaminophen toxicity and protein nitration in freshly isolated hepatocytes","volume":"89","author":"Banerjee","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"20","key":"10.1016\/j.intimp.2024.111937_b0430","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1007\/s00018-014-1662-8","article-title":"Tyrosine nitration as mediator of cell death","volume":"71","author":"Franco","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.intimp.2024.111937_b0435","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1073\/pnas.0904055107","article-title":"Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders","volume":"107","author":"Kwon","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.111937_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101672","article-title":"Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies","volume":"65","author":"Tiwari","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2024.111937_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102418","article-title":"Exploring COX-2 inhibitors in tuberculosis: a whole-blood model approach for immune response and adjunt therapy evaluation","volume":"143","author":"Carranza","year":"2023","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.intimp.2024.111937_b0450","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.669623","article-title":"Plasma LOX-products and monocyte signaling is reduced by adjunctive Cyclooxygenase-2 inhibitor in a phase I clinical trial of tuberculosis patients","volume":"11","author":"Jontvedt Jorgensen","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111937_b0455","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/dkl486","article-title":"Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis","volume":"59","author":"Byrne","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.intimp.2024.111937_b0460","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijantimicag.2007.04.016","article-title":"Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice","volume":"30","author":"Dutta","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7","key":"10.1016\/j.intimp.2024.111937_b0465","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1086\/605605","article-title":"Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant mycobacterium tuberculosis in the guinea pig","volume":"200","author":"Ahmad","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"Pt 6","key":"10.1016\/j.intimp.2024.111937_b0470","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1099\/jmm.0.030932-0","article-title":"Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies","volume":"60","author":"Fauvart","year":"2011","journal-title":"J. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111937_b0475","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4103\/0366-6999.151695","article-title":"Isoniazid and pulmonary fibrosis","volume":"128","author":"Chung","year":"2015","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.1016\/j.intimp.2024.111937_b0480","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/thorax.57.11.1000","article-title":"Pneumonitis induced by rifampicin","volume":"57","author":"Kunichika","year":"2002","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0485","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0149-2918(01)80043-6","article-title":"Linezolid: an oxazolidinone antimicrobial agent","volume":"23","author":"Fung","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.intimp.2024.111937_b0490","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/985302","article-title":"Increased frequency of CD4+ CD25+ FoxP3+ T regulatory cells in pulmonary tuberculosis patients undergoing specific treatment and its relationship with their immune-endocrine profile","volume":"2015","author":"Diaz","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.111937_b0495","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1164\/rccm.201203-0444OC","article-title":"Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis","volume":"186","author":"Fennelly","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2024.111937_b0500","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"37","key":"10.1016\/j.intimp.2024.111937_b0505","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw6693","article-title":"Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo","volume":"4","author":"Rothchild","year":"2019","journal-title":"Sci. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.111937_b0510","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"Verver","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.111937_b0515","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41385-019-0147-3","article-title":"Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis","volume":"12","author":"Khan","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2024.111937_b0520","unstructured":"W.H. Organization, Global tuberculosis report 2021, World Health Organization. (2021)."},{"issue":"9","key":"10.1016\/j.intimp.2024.111937_b0525","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1159\/000516392","article-title":"Defining outcomes of tuberculosis (treatment): from the past to the future","volume":"100","author":"Gunther","year":"2021","journal-title":"Respiration"},{"issue":"9","key":"10.1016\/j.intimp.2024.111937_b0530","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/j.intimp.2024.111937_b0535","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant Pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.111937_b0540","unstructured":"W.H. Organization, WHO consolidated guidelines on tuberculosis module 4: treatment: drug-resistant tuberculosis treatment, World Health Organization. (2020) 132."},{"key":"10.1016\/j.intimp.2024.111937_b0545","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.708522","article-title":"An investigation of the risk factors associated with anti-tuberculosis drug-induced liver injury or abnormal liver functioning in 757 patients with pulmonary tuberculosis","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T04:02:56Z","timestamp":1719979376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924004557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":109,"alternative-id":["S1567576924004557"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111937","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive administration of parabiotic Lactobacillus sakei CVL-001 ameliorates drug-induced toxicity and pulmonary inflammation during antibiotic treatment for tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111937"}}